How US anti-vaxxers found they were not immune to pushback
Recent setbacks for the movement signal a potential turning point for the vaccine makers as the market picks up
Related reading
The blurred line between free speech and medical misinformation
Transparency is key if public fears about vaccines are to be allayed
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
America’s unfortunate backward step on vaccines
2025 has been a good year for immunisation science, but not in the US
Tips for resisting the anti-science lurch
The loss of robust evidence in the public realm harms us all
As measles spreads, old vaccination canards do too
For as long as there have been vaccines, there has been passionate opposition to them
A test for global public health
The decline in funding for vaccinations poses a worldwide threat